AGT and cardiac hypertrophy: In our earlier study, we found that CAPA decreased plasma angiotensin II level in mice with abdominal aortic banding-induced ventricular hypertrophy [34], implicating that the angiotensin II-lowering activity of CAPA may protect the cardiovascular function in diabetes.